| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |